Society of Hematologic Oncology

At #AACR26, @ireneghobrial.bsky.social & Dr. Omar Nadeem discuss the phase II CAR-PRISM trial in high-risk smoldering multiple myeloma. @danafarber.bsky.social Watch more here:https://sohoinsider.com/news/ghobrial-nadeem-ciltacabtagene-autoleucel-smoldering-myeloma-prevention/

Dr. Luke Fletcher discusses the challenges and strategies for building successful research programs in community oncology settings during the latest SOHO Community Oncology Insider session. Watch here: sohoinsider.com/leukemia/dr-...

"This is not a transient issue... cumulatively there will be... cancer issues right down the road." Dr. Shuguang Leng speaks on the long-term cancer risks of cumulative wildfire smoke exposure from #AACR26. @unm.edu sohoinsider.com/news/is-ther...

"There are clear structural barriers to patients getting optimal therapy" sohoinsider.com/cellular-the... Dr. Roy Johnson discusses the opening of a new KU cancer center & how POC CAR-T can alleviate barriers to treatment for patients. #AACR26.

CAR-T is not only effective in younger, fit patients but also in older patients . Hear the full discussion on the new episode of the SOHO Insider podcast with Megan Melody & Nirav Shah 🎧 @medicalcollegeofwi.bsky.social sohoinsider.com/lymphoma/dr-...

The ⏰ is ticking for #SOHO2026 abstract submissions. Don’t miss the May 15 deadline. Cash prizes will be awarded to the top abstracts. Submit your abstract today at soho.click/abstracts

"Accelerating.. bispecific adoption...is the highest impact goal that the research community can currently undertake." Dr. Jeffrey Matous and host Dr. Loretta Nastoupil discuss managing access to novel agents in the community setting. sohoinsider.com/cellular-the...

Listen to our podcast from #SOHOUK, with Gloria Iacoboni & James Day. The pair discuss improving CAR-T outcomes in lymphoma. sohoinsider.com/news/gloria-...

Dr. Andrew Lane discusses the improved outcomes of the Tag-Aza-Ven triplet over standard single-agent therapy for aggressive BPDCN at #ASH2025. sohoinsider.com/meetings-con...

Listen to our podcast from SOHO UK on why clinicians should lead hospitals with Prof. Amanda Goodall & Prof. Chris Fox on the SOHO Insider podcast #SOHOUK. sohoinsider.com/news/when-do...

We are highlighting SOHO UK this week & our lymphoma host Dr. Megan Melody who speaks with Kate Cwynarski on what to expect in her sessions focused on CNS lymphoma and T-cell lymphoma. sohoinsider.com/lymphoma/pro...

Prof. Craddock discusses 1st SOHO UK set for 3–4 March 2026 in London sohoinsider.com/ambassador-p...

"Patients do not have to remain at the CAR_T site if they're doing well." Catch the latest SOHO Insider Brown Bag Series as Loretta Nastoupil and Dr.Tara Graff explore new pathways for returning CAR-T patients to community care sooner. #CommunityOncology #CARTcell sohoinsider.com/cellular-the...

"We can unite & validate our findings together as a region & we can validate our data with our international colleagues." In this interview from SOHO Asia 2026, Dr. Yu-Hung Wang discusses the strategic importance of regional unity in research. sohoinsider.com/news/soho-as...

SOHO President Dr. John DiPersio speaks on why cross-sector partnerships are needed to sustain innovation in blood cancer treatment . The #SOHO2026 theme will focus on sustaining research with public-private partnerships. sohoinsider.com/news/john-di...

"The goal of the next generation of therapies is ... about trying to delay the natural history of the disease," Douglas Tremblay says about ET in the latest SOHO Insider podcast episode with host Dr. Andrew Kuykendall. #MedSky sohoinsider.com/myeloprolife...

"CAR-T cell therapy should be defined by biological eligibility and not by geography." 🧬 Watch Dr. Manali Kamdar discuss expanding CAR-T access in the community setting in our Community Oncology Brown Bag series. sohoinsider.com/news/communi... Register at soho.click/community-on...

Dr. Kelly Bolton on ivosidenib in IDH1-mutated CCUS sohoinsider.com/leukemia/dr-...

How to approach 1L patients in follicular lymphoma? Watch our roundtable discussion on the topic. sohoinsider.com/lymphoma/dr-...

Earlier lines of cilta-cel linked to better immune fitness in myeloma sohoinsider.com/news/dr-pare...

Dr. Gwen Nichols, of @bloodcancerunited.bsky.social, discusses financial toxicity in #bloodcancer care. sohoinsider.com/leukemia/dr-...

On this sohoinsider.com podcast, Dr. Tom Martin interviews 1st US patient w/ #myeloma who was treated with cilta-cel (then LCAR-B38M) in China. Stay tuned for the full feature 📰 next week. sohoinsider.com/cellular-the...

“You can think of the catalytic activity somewhat like having a drug that acts like a serial killer...it can degrade each target sequentially, achieving a very high potency," Dr.Chen explains how one Opna degrader molecule hits targets inside #myeloma cells #ASH25 sohoinsider.com/meetings-con...

“Patients who had failed to respond properly to ruxolitinib are now seeing their spleens completely normalize.” Watch Dr. Adam Mead explain why the PROMise trial’s early results could change the outlook in myelofibrosis. #ASH25 sohoinsider.com/myeloprolife...

“This is a great time for both large B-cell and follicular lymphoma patients. We have really good treatment strategies,”Dr. Swetha Thiruvengadam said. sohoinsider.com/roundtable-d...

Watch our video interview with Guillermo Garcia-Manero from #ASH25 on the phase 2 ASTX030 results in #MDS sohoinsider.com/myelodysplas...

“I think there's a need for education...It's usually not a list in terms of priorities. So how do you introduce another therapy into that laundry list of options,” said Dr. Loretta Nastoupil on community adoption of golcadomide in DLBCL. sohoinsider.com/roundtable-d...

Watch our roundtable discussion on CELLMods in LBCL & follicular lymphoma. sohoinsider.com/roundtable-d...

“It’s really exciting to see menin inhibitors moving to frontline AML… we’re already seeing much higher response rates," Dr. Lore Gruenbaum says in this video interview from #ASH2025 buff.ly/x51gcxb

“Bispecifics are like a matchmaker… if it’s a perfect match, fireworks happen!” Dr. Graff said. Listen to our new podcast episode here: sohoinsider.com/lymphoma/tar...

Dr. Al-Ola A Abdallah discusses the DREAMM-7 study in this video interview: sohoinsider.com/video-interv...

Ahead of SBBC, SOHO Insider asked Dr. Vose for her take on the biggest lymphoma developments of 2025. SBBC starts tomorrow. Register today at soho.click/SBBC. SOHO members: it is FREE. Become a SOHO member for free at soho.click/join. sohoinsider.com/lymphoma/a-2...

Does the future of myeloma treatment belong to trispecific antibodies? sohoinsider.com/multiple-mye...

"We ... started these studies in the older patients because we were anxious about treating younger patients with chemotherapy-free regimens," Dr. Short says in this discussion with Dr. Hagop Kantarjian. Watch the video: sohoinsider.com/news/drs-kan...

Watch our video interview with María-Victoria Mateos on the DREAMM-7 study on SOHO Insider. sohoinsider.com/video-interv...

ICYMI: Drs. Susan O'Brien and Nitin Jain discuss FLAIR trial updates plus emerging BTK degraders in relapsed disease in this SOHO Insider podcast episode: sohoinsider.com/leukemia/drs...

"For a transplant-naive patient, we still can advocate to transplanting these patients if they're fit," Dr. Ibrahim T. Aldoss said in this panel discussion on #ALL with Dr. Elias Jabbour and Aaron Logan. Watch the video: sohoinsider.com/news/drs-jab...

Outside of clinical trials, available data with the second-generation TKI dasatinib show very strong results, says Dr. Nicholas Short in this interview with Dr Kantarjian at #SOHO2025. sohoinsider.com/news/drs-kan...

Dr. Kantarjian interviews Dr. Graff on MorningSun trial at #SOHO2025 sohoinsider.com/meetings-con...

ICYMI: Watch Muhammad Bilal Abid, MD, MS, on protecting patients with blood cancers from COVID-19 vimeo.com/1114018882?r...

Drs. Melody, Phillips talk glofitamab in MCL our new SOHO Insider podcast. sohoinsider.com/lymphoma/drs...

The wait is over - #SOHO2025 is finally here! 🎉 👉 Badge pickup is open today from 3-7 PM and tomorrow starting at 6:30 AM on the 3rd Level of the GRB Convention Center. See you soon! Not in Houston? You can still attend virtually! Register at soho.click/2025

We are less than two weeks away from #SOHO2025. Register now at soho.click/2025

New SOHO Insider podcast with Drs. Callie Coombs & host Susan O'Brien on CLL trial updates including GAIA/CLL13 and AMPLIFY trials sohoinsider.com/news/soho-in...

What do the real-world data show on luspatercept in LR-MDS? Find out in this video clip from Dr. Idoroenyi Amanam sohoinsider.com/meetings-con...

SOHO President Phillip Scheinberg talks with Saad Usmani on #SOHO2025 and benefits of SOHO membership. Register today at soho.click/2025. sohoinsider.com/news/drs-saa...

Register now for #SOHO2025 at soho.click/2025

New podcast episode with Drs. Saad Usmani & Sagar Lonial on the journey of belantamab mafodotin in #MM. Listen now. sohoinsider.com/soho-insider...

10K strong & growing!🎉SOHO celebrates a major milestone thanks to you, our incredible community dedicated to advancing hematologic oncology worldwide. Let’s continue to innovate, collaborate & transform patient care together! Not a member? Join SOHO for free: soho.click/join #medsky #hemonc

Hey from #EHA25 in Milan!👋 Stop by SOHO booth M17 (next to the Exhibitor Service Center) to say hi, pick up the latest SOHO Insider, & get the latest SOHO updates! Note: SOHO is no longer affiliated with BCT. #EHA2025 #MedSky #HemOnc

One of the key messages from the paper is to not make a quick decision on early delivery, says Dr. Kidson-Gerber. #pregnancy #bloodcancers sohoinsider.com/news/blood-c...